As of Aug 24
| -0.18 / -5.59%|
The 5 analysts offering 12-month price forecasts for Anthera Pharmaceuticals Inc have a median target of 10.00, with a high estimate of 14.00 and a low estimate of 9.00. The median estimate represents a +228.95% increase from the last price of 3.04.
The current consensus among 5 polled investment analysts is to Buy stock in Anthera Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.